Shanghai firm rolls
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Commonwealth Games ~ Nobel Prizes ~ Kim Jong-il ~ Hamid Karzai ~ Ed Miliband ~ Tony Abbott ~ Kathleen Sebelius ~ US Elections ~ Other International News
Home / International News / 2009 / June 2009 / June 27, 2009
Shanghai firm rolls out antiviral drug to combat swine flu
RSS / Print / Comments

Swine Flu

Tamiflu may prevent pneumonia in swine flu patients

Chewed gum wall in US is world's 2nd most unhygienic tourist attraction

Comic books could educate young men about testicular cancer: Study

More on Swine Flu

Bird Flu

Why bird flu didn't become a pandemic

Dead pigeons, boa constrictor among top weird finds at UK airports

Frost & Sullivan: Medical Waste Finds Growth in Malaysia's Robust Healthcare System

More on Bird Flu

Top News

144 Section in Hyderabad ahead of Ayodhya verdict

Trinamool accuses CPI (M), police of harassing and arresting party workers

Airline captain dies while flying plane from Philippines to Qatar

Russell Brand and Katy Perry want their wedding to be 'normal'

Foreign investors eyeing India to avoid West's economic doldrums

Anjali Tendulkar expresses happiness over Sachin's double century against Australia

Yoga may have the power to fight fibromyalgia

Watermelon effectively lowers BP

Shanghai firm rolls out antiviral drug to combat swine flu

A pharmaceutical company in Shanghai has rolled out the first batch of antiviral drugs to combat Influenza A (H1N1) virus, which is responsible for the swine flu pandemic around the world.


Shanghai, June 27 : A pharmaceutical company in Shanghai has rolled out the first batch of antiviral drugs to combat Influenza A (H1N1) virus, which is responsible for the swine flu pandemic around the world.

The Shanghai Pharmaceutical (Group) Co. Ltd. has manufactured 256,000 Oseltamivir Phosphate Capsules, after all the quality tests required were passed.

"The antiviral drug, or the Chinese version of Tamiflu by Swiss drugmaker Roche Holding, was first produced in 2005 to cope with the bird flu outbreak with the authorization of Roche," said Xinhua quoted Wu Jianwen, president of Shanghai Pharmaceutical, as saying.

The Shanghai Pharmaceutical had closed down production of Oseltamivir Phosphate Capsules in 2007, however, following a call from the central government to combat the A(H1N1) flu, it resumed production of the pill in April 2009.

"Currently, we'll be able to turn out 2 million pills per month, and we can expand the output capacity in the future if the flu epidemic shows new changes," said Wu Jianwen.

According to the Chinese Ministry of Health, China has at least 570 confirmed cases of A(H1N1) flu, but no fatalities have been reported.

Meanwhile, China has also set up laboratory tests on the country's first developed A(H1N1) flu vaccine, with the help of the seed virus that they have received from a World Health Organization (WHO) lab.

The vaccine will undergo a 14 day safety tests in labs and two-month of clinical tests from July. Subsequently, it is expected to be available in markets in September.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us